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Protein degradationThe N-terminal amphipathic helixα0 of hepatitis C virus (HCV) NS3 protein is an essential structural determinant
for the proteinmembrane association. Here, we performed functional analysis to probe the role of this helixα0 in
the HCV life cycle. A point mutation M21P in this region that destroyed the helix formation disrupted the
membrane association of NS3 protein and completely abolished HCV replication. Mechanistically the mutation
did not affect either protease or helicase/NTPase activities of NS3, but signiﬁcantly reduced the stability of NS3
protein. Furthermore, the membrane association and stability of NS3 protein can be restored by replacing the
helix α0 with an amphipathic helix of the HCV NS5A protein. In summary, our data demonstrated that
the amphipathic helix α0 of NS3 protein determines the proper membrane association of NS3, and this
subcellular localization dictates the functional role of NS3 in the HCV life cycle.
© 2011 Elsevier Inc. All rights reserved.Introduction
Hepatitis C virus (HCV) is the member of the distinct Hepacivirus
genus in Flaviviridae family. Its infections are often persistent and
lead to chronic hepatitis, which can develop into liver cirrhosis, and
hepatocellular carcinoma. Currently, over 170 million peopleworldwide
are infected with HCV. The standard of care is the combination therapy
of interferon-a (IFN-a) and ribavirin, however, the effectiveness of this
treatment is insufﬁcient especially for the patients infected with HCV
of genotype I.
HCV contains a 9.6-kb positive single-stranded RNA genome that
encodes a polyprotein precursor of about 3000 amino acids ﬂanked
by 5′- and 3′-UTR regions that are important for translation and
replication of the viral RNA (Moradpour et al., 2002; Takamizawa et
al., 1991). The polyprotein precursor is co- and post-translationally
processed by cellular and viral proteases to yield mature structural
(Core, E1, E2) and nonstructural proteins (p7, NS2, NS3, NS4A, NS4B,
NS5A and NS5B) (Hijikata et al., 1991, 1993; Reed and Rice, 1998;
Shimotohno et al., 1995). NS3 is a bifunctional molecule with an
N-terminal serine protease domain which, together with the NS4A
cofactor, is essential for cleavage at NS3/4A, NS4A/4B, NS4B/5A
and NS5A/5B sites, and a C-terminal domain functioning as an RNA
helicase/NTPase (Bartenschlager et al., 1993; Eckart et al., 1993;
Grakoui et al., 1993b; Kim et al., 1995). In addition, NS3 is the cofactori, Chinese Academy of Science,
ax: +86 21 63859365.
rights reserved.of NS2 cysteine autoprotease responsible for cleavage at NS2/NS3
site. Both enzyme activities have been well characterized, and
high-resolution structures havebeen solved. The serineproteasedomain
adopts a chymotrypsin-like fold with residues H57, D81 and S139
forming its catalytic triad (Kim et al., 1996). The NS3 helicase unwinds
RNA and DNA homoduplexes and heteroduplexes in a 3′ to 5′ direction
(Kim et al., 1995).
Formation of amembrane-associated replication complex, composed
of viral proteins, replicating viral RNA, and altered cellularmembranes, is
a hallmark of all plus-strand RNA viruses including HCV. HCV RNA
replication occurs in association with altered cytoplasmic membranes
which are termed as “membranous web” (Egger et al., 2002;
Moradpour et al., 2003). NS4B is sufﬁcient to induce the membranous
web formation and has been proposed to serve as a scaffold for
replication complex assembly. NS5B, the RNA-dependent-RNA
polymerase, is an essential component of this RNA replication
machinery (Lohmann et al., 1997). Almost all the HCV nonstructural
proteins have been studied for structural determinants of membrane
association. The N-terminal domain of NS4A is predicted to form a
transmembrane α-helix involved in membrane anchorage of the
NS3-4A complex (Brass et al., 2008; Gosert et al., 2005). Moradpour
et al. (Gouttenoire et al., 2009b) reported that an amphipathic
α-helix at the C terminus of NS4B (amino acid residues 229 to 253)
was essential for membrane association and was involved in the
formation of a functional HCV replication complex. In addition,
an amphipathic α-helix extending from amino acids 5 to 25 of the
N-terminus of NS5A was identiﬁed as a membrane anchor domain
by NMR spectroscopy (Penin et al., 2004). For NS3, the amphipathic
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Fig. 1. M21P destroyed the N-terminal amphipathic helix α0 of NS3. A. Schematic
representation of amino acids 10–24 of wild-type and M21P mutant NS3 protein
(JFH1 strain). The point mutation at position 21 is indicated by the asterisk. Nucleotides
(1040–1050) and amino acids (10–20) are numbered according to the HCV polyprotein
and NS3 respectively. B. Prediction of the secondary structure of amino acids 10–24
segment of NS3 using Agadir software (http://agadir.crg.es/) (Munoz and Serrano,
1994) for the helix contents. C. Circular dichroism analysis of peptides encompassing
the amino acids 10–24 of wild-type and M21P mutant NS3 proteins.
215Y. He et al. / Virology 422 (2012) 214–223helixα0, formed by the N-terminal amino acid residues 12–23 highly
conserved among HCV genotypes, was reported to serve as an essential
structural determinant for the membrane association of the NS3-NS4A
complex. However, the detailed virological and biological functions of
this amphipathic helix in the HCV life cycle have not been fully
explored.
Here we analyzed the detailed functions of the amphipathic helix
α0 of NS3 in the HCV life cycle. We demonstrated that the helix α0
served as the primary structural determinant for the membrane
association of NS3 and NS3/4A protease complex, and this subcellular
localization prevented the degradation of the NS3 protein.
Results
M21P mutation destroyed the N-terminal amphipathic α helix of NS3
protein
Aprevious studydemonstrated that theN-terminal 10–24 residues of
HCV NS3 protein formed an amphipathic helixα0, a critical determinant
for ER membrane association of NS3-NS4A complex (Brass et al., 2008).
However, the biological function of this α helix in HCV life cycle has
not been fully explored. We engineered a point mutation (M21P) from
methionine to proline at amino acid 21 of NS3 of JFH1, a genotype 2a
HCV strain (Fig. 1A). Secondary structure prediction analysis indicated
that the M21P mutation impaired the helix structure formation, as the
predicted overall 22% helix content for the wild-type decreased to 11%
for the mutant peptide (Fig. 1B). This prediction was further conﬁrmed
by circular dichroism analysis of the peptides covering the N-terminal
10–24 amino acids of JFH1 NS3 protein. As shown in Fig. 1C, the
wild-type peptide displayed a typical alpha helix absorption curve,
while the M21P peptide did not. These results demonstrated that the
M21P mutation destroyed the N-terminal amphipathic alpha helix of
NS3.
Disruption of the helix α0 did not affect NS3 helicase/NTPase activities
HCV NS3 protein is a multifunctional protein with helicase and
NTPase activities in the C-terminal two-thirds. Therefore, we examined
whether disruption of α0 at the N-terminus affected the helicase/NTP
activities. We expressed and puriﬁed His-tagged wild-type and M21P
mutant recombinant NS3 proteins. All recombinant NS3 proteins were
puriﬁed to greater than 95% purity (Fig. 2A). Next we examined the
helicase and NTPase activities of recombinant NS3 proteins using the
previously reported assays (Zhang et al., 2005). For the helicase assay,
a synthetic 30-nucleotide 5′-end 32P-radiolabeled oligonucleotide was
annealed to a 54-nucleotide single-stranded DNA to form a partially
duplex DNA substrate with 5′ and 3′ overhanging ends. Upon
unwinding by NS3 helicase, the 30-nucleotide labeled DNA strand
was released and trapped by a complementary capture strand to
form a duplex. As shown in Fig. 2B, both the wild-type and M21P
NS3 proteins efﬁciently unwound the DNA duplex substrate in a
dose-dependent manner. Similarly, for the NTPase assay, the wild-type
and M21P NS3 proteins hydrolyzed γ-32P GTP with comparable
efﬁciencies (Fig. 2C). These results demonstrated that the M21P
mutation did not affect the helicase or NTPase activities of NS3.
Disruption of the helix α0 abolished HCV replication
To determine the functional role of the NS3 helix α0 in HCV life
cycle, the M21P mutation was introduced into pSGR-luc-JFH1, a
bi-cistronic subgenomic replicon that expressed ﬁreﬂy luciferase, for
direct detection of luciferase as a measurement of HCV RNA replication
capacity (Targett-Adams and McLauchlan, 2005). Wild-type, M21P
mutant and NS5B polymerase defective GND mutant (Wakita et al.,
2005) in vitro transcribed replicon RNAs were electroporated into
Huh7 cells, and luciferase activities were measured at 4, 24 and48 h post-electroporation. As shown in Fig. 3A, the luciferase activity
of the wild-type replicon increased about 30-fold after 48 h of
electroporation, whereas the luciferase activity of the M21P and
GND replicons declined below the basal levels after 4 h, indicating
the M21P mutation abolished the HCV RNA replication.
Next, we used the infectious HCVcc system (Lindenbach et al.,
2005; Wakita et al., 2005; Zhong et al., 2005) to examine the effect
of the M21P mutation on HCV life cycle. Wild-type and M21P mutant
JFH1 genomic RNAs were electroporated into Huh7.5.1 cells. Consistent
with the results of subgenomic replicon transfection, M21P mutant
JFH1 RNA did not produce infectious viruses, whereas wild type
displayed viral expansion kinetics as previously described (Zhong et
al., 2005), with extracellular infectivity titers peaking at 1500 ffu/ml on
day 21 post-electroporation (Fig. 3B). Furthermore, immunoﬂuorescent
staining of HCV E2 proteins indicated that cells transfected with M21P
mutant remained negative throughout the entire experiment (Fig. 3C),
strongly suggesting that the M21P mutation completely abolished HCV
replication.
Next, we examined the effects of the M21P mutation on HCV
non-structural protein expression. Plasmids that contain wild-type,
M21P, a NS3 protease-defective mutant H57A (Bartenschlager et al.,
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Fig. 2. Disruption of helix α0 did not affect the NTPase/helicase activity of NS3. A. SDS-PAGE analysis of puriﬁed recombinant wild-type and M21P NS3 proteins. Ten picomoles of
each protein were loaded onto 10% SDS-PAGE gels and visualized by Coomassie blue staining. Molecular mass markers are on the left. B. Helicase activity of wild-type and M21P
mutant NS3 proteins. Helicase activity was measured with a radio-labeled double-stranded DNA substrate unwound by 0.5 or 1 pmole of wild-type and M21P mutant NS3 proteins,
and quantiﬁed with a PhosphorImager. The percentage of input, calculated as the ratio of the product over the total input (substrate+product), was indicated at the bottom.
Schematic representation of the assay is shown on the top. C. NTPase activity of wild-type and M21P mutant NS3 proteins. 5 pmol [γ-32P] GTP was incubated with an aliquot of
5 pmol NS3 proteins at 37 °C for 30 min and the radioactive phosphate product was separated by the thin-layer chromatography and quantiﬁed with a PhosphorImager. The
NTPase activity expressed as the percentage of radioactive phosphate converted from input [γ-32P] GTP was indicated at the bottom.
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Fig. 3. Disruption of helix α0 abolished HCV replication and virus production A. The luciferase activity of JFH1 subgenomic replicon expressing the wild type, M21P or GND. The
subgenomic luciferase reporter replicon is a bicistronic RNA containing ﬁreﬂy luciferase expressed via the HCV's IRES and NS3-5B proteins expressed via the EMCV's IRES (Lohmann
et al., 1999). The in vitro transcribed replicon RNA was electroporated into Huh7.5.1 cells and the luciferase activities were measured at the indicated times. The error bars were
calculated from 4 independent experiments. B. The supernatant infectivity titers of JFH1 HCVcc containing the wild-type or M21P mutant NS3. The in vitro transcribed full-
length genomic JFH1 RNA containing the wild-type or M21P mutant NS3 were electroporated into Huh7.5.1 cells, and the culture supernatants were harvested at the indicated
times post-electroporation, and determined for the infectivity titers. The error bars were calculated from 3 independent experiments. C. The E2 immunostaining of Huh7.5.1
cells at day 2 and 18 post-electroporation. E2 staining was in red and nuclei were stained with Hoechst (blue). D. Western blot analysis of HCV non-structural protein expres-
sion. Plasmids expressing the wild-type, M21P, H57A or GND of JFH1 NS3-NS5B were transfected into Huh7.5.1 cells, and the cell lysates were collected at day 2 post-
transfection for western blot. Expressions of HCV NS3 (72 kDa), NS5A (two bands corresponding to p56 and p58, around 72 kDa), NS5B-FLAG (72 kDa) and actin (45 kDa)
are shown from top to bottom.
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regionwere transfected intoHuh7.5.1 cells, and theNS3, NS5A andNS5B
protein levels were determined at day 2 post-transfection. As shown in
Fig. 3D, NS3, NS5A and NS5B protein levels were dramatically decreased
for M21P and H57A compared to wild-type and GND mutant. Since the
maturation of NS5A and NS5B proteins is carried out by the NS3/NS4A
serine protease, the decreased NS5A and NS5B levels of M21P mutant
were likely caused by insufﬁcient NS3 protein level. Altogether,
these data suggested that the disruption of N-terminal helix α0
of NS3 protein reduced NS3 protein levels and abolished HCV
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Fig. 4. Disruption of helixα0 reduced the stability of NS3 protein. A.Western blot analysis
of NS2 and NS3 proteins. The plasmids expressing HA-tagged NS2 fused with wild-type,
M21P orH57ANS3were transfected intoHuh7.5.1 cells, and the cell lysateswere collected
at 48 h post transfection and analyzed by western blot using antibodies speciﬁc for HA or
NS3. B.Western blot of NS3 and NS4A proteins. The plasmids expressing wild-type, M21P
or H57A NS3 fused with FLAG-tagged NS4A were transfected into Huh7.5.1 cells, and the
cell lysates were collected at 48 h post transfection and analyzed by western blot using
antibodies speciﬁc for NS3 or FLAG. C. Western blot of NS3 with or without MG132
treatment. Huh7.5.1 cells were transfected with the plasmids expressing wild-type,
M21P or H57A NS3 fused with NS4A for 24 h, and then treated with 5 μM MG132
(sigma) for 16 h. The cell lysates were analyzed by western blot. The relative expression
levels of NS3 proteinswere quantiﬁed by ImageJ and the fold-change of NS3 protein levels
are indicated at the bottom. Actin was used as the internal control in all experiments.Disruption the helix α0 led to NS3 degradation
The reduced NS3 protein level of M21P mutant could be because
cleavage between NS2 and NS3 or NS3 and NS4A was affected by
the M21Pmutation, or the M21P NS3 protein was unstable. We tested
each of these possibilities.
Because the autoprotease activity of NS2 requires both NS2 and
the N-terminal 181 amino acids of NS3 (Grakoui et al., 1993b;
Schregel et al., 2009), we ﬁrst investigated whether the M21P
mutation in the N-terminus of NS3 affected NS2 protease activity.
Plasmids expressing N-terminal HA-tagged NS2 protein fused
with the wild-type, M21P, H57A NS3 were transfected into
Huh7.5.1 cells. Cell lysates were collected at 48 h post-transfection
and analyzed by western blot. As shown in Fig. 4A, the HA-NS2
expression levels were comparable among the wild type and mutants,
whereas the NS3 levels were signiﬁcantly reduced in theM21Pmutant,
suggesting that cleavage at the NS2 and NS3 junction was not affected
by the M21P mutation in NS3.
Next, we examined whether the M21P mutation affected cleavage
at the NS3/NS4A junction. Plasmids that expressed the wild-type,
M21P, or H57A mutant NS3 protein fused with a C-terminal FLAG-
tagged NS4A were transfected into Huh7.5.1 cells. Cell lysates were
collected at 48 h post-transfection and analyzed by western blot. As
shown in Fig. 4B, both NS3 and FLAG-tagged NS4A proteins were
detected for the wild type, indicative of efﬁcient cleavage between
NS3 and NS4A. In contrast, for the protease-defective H57A construct,
neither NS3 nor NS4Awas detected, and uncleaved NS3/NS4A protein
was detected by both anti-NS3 and anti-Flag antibodies. Interestingly,
for the M21P mutant, NS3 protein was barely detected although
mature NS4A was detected with no uncleaved NS3/NS4A product.
These results suggested that the cleavage at the NS3/4A junction
by NS3 protein was not affected by the M21P mutation. Instead, this
mutation may possibly affect NS3 stability, and decreased level of
mature NS4A in theM21Pmutant construct may reﬂect the instability
of NS3/NS4A precursor.
To evaluate the effect of the M21P mutation on the stability of NS3
protein, we transfected plasmids expressing wild-type, M21P, or
H57A NS3-NS4A proteins into Huh7.5.1 cells, and added proteasomal
inhibitor MG132 on day 1 post-transfection to inhibit protein
degradation. Cell lysates were collected 48 h later, and analyzed
by western blot. As shown in Fig. 4C, the M21P NS3 expression
level was much lower than the wild-type and H57A NS3. However,
in the presence of MG132, the M21P NS3 protein level increased
about 3.52-fold whereas the wild-type increased only 1.26-fold and
H57A NS3 increased 1.54-fold, indicating that the M21P NS3 protein
was more prone to degradation. The restoration of mature M21P NS3
protein level by the proteasomal inhibitor also suggested that the
M21P mutation did not impair the NS3 protease activity catalyzing
the NS3-NS4A cleavage. We noted that a larger band appeared
above the wild-type and M21P NS3 protein in the presence of
MG132, and this band likely represented the uncleaved NS3-4A
precursor possibly due to the inﬂuence of MG132 on the NS3 protease
activity.Taken together, these results demonstrated that disruption of the
amphipathic helix α0 of NS3 protein did not affect cleavage at the
NS2/3 and the NS3/4A junctions but signiﬁcantly reduced NS3
stability.
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stability
A previous study showed that the amphipathic helix α0 was an
important structural determinant for NS3 membrane association
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219Y. He et al. / Virology 422 (2012) 214–223a punctuate, membrane-associated ﬂuorescence pattern in roughly 45%
of GFP-positive cells, whereas theﬂuorescence of NS310–24M21P-GFPwas
diffuse through the cytoplasm and nucleus, similar to the vector control.
To conﬁrm the localization difference between wild-type and
M21P NS3, we transfected plasmids expressing wild-type or M21P
mutant NS3-4A into Huh7.5.1 cells and MG132 was added to the
M21P mutant transfected cells for inhibition of its degradation. Cell
lysates were fractionated and subjected to western blot using
calnexin, a known ER transmembrane protein, as a marker for the
membrane fraction and the cytosol-localized inhibitor of apoptosis
protein cIAP-1 for the cytosolic fraction. As shown in Fig. 5B, the
wild-type NS3 protein was mainly localized in the membrane
fraction with only a small amount in the cytosolic fraction,
whereas the majority of M21P mutant NS3 protein was recovered
in the cytosolic fraction. This result was further conﬁrmed by a
membrane ﬂoatation assay in which the wild-type NS3 proteins
were distributed to a wider range of fractions whereas the M21P
NS3 proteins were mostly distributed to the bottom fractions
(Fig. 5C). Altogether, these results demonstrated that NS3-M21P
lost the ability to associate with the membrane.
Previous work demonstrated that the N-terminal 22 amino acids
of NS3 were important for interaction of NS3 with NS4A (Failla et
al., 1995), and NS4A increased the stability of NS3 (Satoh et al.,
1995), raising a possibility that the M21P mutation may destabilize
NS3 by disrupting the NS3-NS4A interaction. To test this possibility,
we used the in vitro Biacore assay to examine the NS3 and NS4A
interaction, using puriﬁed recombinant NS3 proteins (Fig. 2A)
and in vitro synthesized NS4A peptide. The interaction between
NS3 and NS4A was analyzed with NS4A coupled to the chip by biotin
labeled at its C-terminus and NS3 injected as the analyte in a serial
dilution. As shown in Fig. 5D, the binding of wild-type and M21P
mutant NS3 to NS4A appeared similar. In addition, when the sensor-
grams were analyzed by a 1:1 binding model, global ﬁtting revealed
that the afﬁnity of NS3 wild-type to NS4A was KDWT=7.76 nM and
the M21P mutant to NS4A was KDM21P=4.16 nM. The association
rate constant of M21P (konm21p=14600 M−1 s−1) was slightly
higher than wild-type (konwt=9763 M−1 s−1) and the dissociation
rate constant of M21P (koffm21p=0.000061 s−1) was similar to
wild-type (koffwt=0.000076 s−1). All these results demonstrated
that the disruption of the NS3 helix α0 did not affect the physical
binding of NS3 to NS4A.
Restoration of NS3 membrane association rescued its stability
Next we tested whether the restoration of membrane association
of NS3 protein could rescue the stability of the NS3 protein. It has
been reported that amino acids 5 to 25 of the N-terminus of HCV
NS5A protein also form awell-deﬁned amphipathic alpha helix allowing
for themembrane association of NS5A (Penin et al., 2004). Therefore, we
replaced NS3 helix α0 with the JFH1 NS5A amphipathic helix (Fig. 6A).
As shown in Fig. 6B, the NS3 expression level of the NS3-NS5Ahelix
was comparable to that of wild type and higher than that of M21P
mutant. Furthermore, the fractionation analysis showed that the NS3
protein of the NS3-NS5Ahelix was mainly located in the membrane
fraction, similar to wild-type, indicating that restoration of NS3 mem-
brane localization could restore its stability (Fig. 6C).
Nextwe investigated whether the replacement of NS3 helixα0 with
the NS5A amphipathic helix could further rescue HCV replication. We
introduced the NS5A helix sequence into the NS3 helix α0 region of
Rz-JFH-1, a previously reported plasmid-based system with the
full-length JFH1 cDNA ﬂanked by two self-cleaving ribozymes to
produce HCVcc upon plasmid transfection (Kato et al., 2007) and
transfected into Huh7.5.1 cells. As shown in Fig. 6D, almost no mature
NS3 protein was detected in the Rz-NS5Ahelix transfected cells. Since
cleavage between the NS3-5Ahelix and 4A was intact and the cleaved
NS3 was stable, we hypothesized that cleavage at the NS2 and NS3junction was affected by the heterologous replacement. To test
this hypothesis, we engineered the NS5A helix into the HA-NS2-3
construct and transfected into Huh7.5.1 cells. As shown in Fig. 6E,
no cleaved NS2 or NS3 was detected in the HA-NS2-3-NS5A helix-
transfected cells, suggesting although the NS5A amphipathic helix
could restore the NS3 subcellular localization but disrupt the NS2-3
cleavage, thereby impairing HCV replication.
Nextwe examinedwhether NS3-5Ahelix affected the replication of
an HCV subgenomic replicon. The in vitro synthesized HCV bi-cistronic
subgenomic RNA expressing ﬁreﬂy luciferase was electroporated into
Huh7 cells, and luciferase activities were measured at 4, 24 and 48 h
post-transfection using the same assay described in Fig. 3A. As
shown in Fig. 6F, replacement of NS3 helix α0 with NS5A helix failed
to rescue HCV RNA replication despite that it could restore the
membrane association and protein level of NS3, suggesting that NS3
helix α0 may contribute to HCV replication by more than dictating
the subcellular localization and promoting stability of NS3 protein.
Finally, we investigated whether the replacement of the JFH1 NS3
helix α0 with the same segment of different HCV genotypes could
restore NS3 membrane localization, stability and HCV replication.
As shown in Fig. 7A, the sequence of NS3 helix α0 is highly conserved,
only varying at positions 13, 16, 18, 19 and 21 among H77C (genotype
1a), Con1 (genotype 1b), SA13 (genotype 5a) and JFH1. We replaced
the NS3 helix α0 in Rz-JFH-1 construct with the same segment of
H77C (identical to Con1) or SA 13 and transfected into Huh7.5.1
cells. As shown in Fig. 7B, at 48 h post-transfection, HCV core, NS3
and NS5A displayed comparable expression levels in Rz-H77C,
Rz-SA13, and Rz-JFH1 transfected cells. Furthermore, both Rz-NS3-
H77Chelix and Rz-NS3-SA13helix displayed comparable amounts of
HCV-positive cells to wild-type on day 6 post transfection while
Rz-NS3-M21P showed no HCV-positive cells (Fig. 7C). This clearly
demonstrated that NS3 stability and HCV replication capability were
restored by homologous replacement of the JFH1-NS3helix with
H77C or SA13 NS3 helix α0.
Discussion
Eukaryotic intracellularmembrane organelles are highly organized
structures and provide essential places for occurrence of numerous
biological events. Many intracellular pathogens such as viruses
have evolved to utilize these membrane structures for their own
survival. HCV replication occurs in a membrane-derived replication
complex consisting of viral genome and nonstructural proteins
that require correct subcellular localization for their functions in
the viral life cycle. The previously identiﬁed N-terminal amphipathic
helix α0 of HCV NS3 protein was an important structural determinant
forNS3membrane association (Brass et al., 2008). Herewedemonstrated
that impaired membrane association of NS3 by a point mutation (M21P)
or the deletion of the entire helix α0 (data not shown) reduced the
stability of NS3 protein, while had no effect on the protease and
helicase/NTPase activities of NS3, proteolytic cleavages at NS2/NS3
and NS3/NS4A sites, or the interaction between NS3 and NS4A.
When the helix α0 was replaced with an amphipathic helix derived
from HCV NS5A protein, the membrane association and stability of
NS3 protein were both restored. Furthermore, inhibition of cellular
proteasome could restore the NS3 stability, but not the membrane
association (Fig. 5B). From these data we concluded that the helix
α0 allowed the NS3-NS4A precursor or the mature NS3 protein to
associate with the membrane, which avoided protein degradation
by the cellular degradation machinery. Therefore, the helix α0 was
not only the determinant for the subcellular localization of NS3, but
also the determinant for the protein stability.
A previous study showed that NS4A, the cofactor of NS3 serine
protease, could help NS3 localize to membrane and stabilize NS3
protein (Tanji et al., 1995). In our study, we found that the disruption
of the helix α0 led to the membrane dissociation and degradation of
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Fig. 6. A NS5A-derived amphipathic α helix could restore NS3 membrane association and its stability. A. Schematic representation of replacement of NS3 helix α0 with the
N-terminal 5–25 amino acids of NS5A amphipathic α helix. B. Western blot analysis of NS3 expression with helix α0 replaced with the NS5A amphipathic α helix. Huh7.5.1
cells were transfected with plasmids expressing the wild-type, M21P or NS5A-helix chimeric NS3-NS4A proteins, and the cell lysates were collected at day 2 post-transfection
and analyzed by western blot. C. Western blot analysis of NS3 proteins in the cytosolic and membrane fractions. The Huh7.5.1 cells expressing the wild-type or NS5A-helix
fused NS3 proteins were subjected for the separation of cytosolic and membrane fractions. The total cell lysates and each fraction were analyzed by western blot. cIAPI, a cytosolic
protein, and calnexin, an ER protein, were included as the marker for the cytosolic and membrane fractions respectively. D. Western blot analysis of NS3 and core in the cells transfected
with the plasmids expressing HCVcc. Rz-JFH1-WT, Rz-JFH1-M21P, Rz-JFH1-H57A, Rz-JFH1-GND, or Rz-JFH1-NS5Ahelix were transfected into Huh7.5.1 cells to examine viral production.
At 48 h post transfection, cells lysates were analyzed by western blot for HCV Core and NS3 protein expressions. E. Western blot analysis of HCV NS2 and NS3 proteins. The plasmids
expressing HA-taggedNS2 fusedwithwild-type,M21P, H57A orNS5A-helix chimeric NS3were transfected intoHuh7.5.1 cells, and the cell lysateswere collected at 48 h post transfection
and analyzed by western blot using antibodies speciﬁc for HA or NS3. F. The luciferase activity of JFH1 subgenomic replicon expressing the wild type, 5Ahelix or GND. A representative
experiment of three independent repetitions, each measured in duplicate was shown.
220 Y. He et al. / Virology 422 (2012) 214–223NS3 even though it did not affect the NS3-NS4A interaction. This
suggested that NS4A alone was not sufﬁcient enough to confer the
membrane association and stability of NS3 protein. In fact, the
helix α0 defective NS3-NS4A (M21P) displayed not only the reduced
NS3 protein level but also the reduced NS4A protein level (Fig. 4B),
likely reﬂecting the reduced stability of uncleaved NS3-NS4A precursor.
On the contrary, the protease defective NS3-NS4A (H57A) displayed
high expression level of uncleaved NS3-NS4A precursor despite that it
could not produce the mature NS4A cofactor. Therefore, we proposed
that the helix α0 served as the primary structural determinant of
uncleavedNS3-4A precursor for its subcellular localization and stability.
After the cleavage at the NS3-NS4A site was completed, the N-terminal
transmembrane domain of NS4A inserted into the membrane (Brass et
al., 2008; Gosert et al., 2005) and its central domain bound to NS3
(Bartenschlager et al., 1995), further stabilizing the membrane
association of the NS3/NS4A complex.
Because of the importance of the NS3 amphipathic helix α0 in the
HCV life cycle, strategies to interfere with the structure and function of
thehelixα0may antagonizeHCV infection. TheN-terminal amphipathic
α-helix AH2 of NS4B (4BAH2) was a major determinant for NS4B
oligomerization, membrane association as well as NS4B-meidated
aggregation of lipid vesicles, and was essential for the HCV genomereplication (Gouttenoire et al., 2009a, 2010). In vitro screening
yielded a class of small molecule inhibitors that targeted the
4BAH2 to prevent HCV replication by destroying the helix functions
in oligomerization or membrane association (Cho et al., 2010). The
similar strategy could be employed to screen inhibitors that either
disrupt the formation of NS3 helix α0 or impair its association with
membrane. Such inhibitors could be a good addition to the current
anti-HCV development many of which target the active sites of the
NS3 protease.
Materials and methods
Plasmids and antibodies
pET21b-JFH1-NS3-WT was constructed by PCR ampliﬁcation of a
JFH1-NS3 fragment from pUC-JFH1 (Kato et al., 2003) and cloning
into the NheI and XhoI sites of pET21b (Novagen, Madison, WI,
USA). Plasmids pEF/JFH1-Rz/S and pEF/JFH1–GND-Rz/S constructs
were kindly provided by Dr. Jake Liang (National Institutes of Health,
USA). Plasmid pHA-NS2-3-WT was constructed by PCR ampliﬁcation
of a JFH1 NS2-3 fragment from pUC-JFH1 and cloning into the
BamHI and XbaI sites of pIPHA2 (Li et al., 2007). pHA-NS2-3-
AB
C
Fig. 7. NS3 stability and HCV RNA replication were restored by replacement of NS3
with the same segment from other HCV genotypes. A. Alignment of NS3 helix α0
sequences of different HCV genotypes. Amino acids are numbered with respect to NS3
of JFH1 strain. Consensus sequences are shaded gray and the NS3 helix α0 indicated
by a line below. B. Western blot analysis of wild-type and chimeras viral proteins in
the Huh7.5.1 cells transfected with the Rz plasmids expressing HCVcc, The cell lysates
were collected at 48 h post transfection and examined by western blot for HCV Core,
NS3 and NS5A expressions. C. Immunoﬂuorescence of E2-positive Huh7.5.1 cells
transfected with Rz-JFH1-WT andmutant/chimera constructs at 6 days post transfection.
Nuclei (blue) were stained with Hoechst dye.
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NS3 helix α0 fragment with the helix of NS5A. Plasmid pNS3-4A-
3ﬂag-WT was constructed by PCR ampliﬁcation of a NS3-4A fragment
from pUC-JFH1 and cloning into the HindIII and XbaI sites of
p3XFLAG-CMV-14 (Sigma, St. Louis, MO, USA). Plasmids pNS310-
24wt-GFP were constructed as described in (Brass et al., 2008). Brieﬂy,
oligonucleotides NS3-10-24wt-fwd and NS3-10-24wt-rev were
hybridized and ligated into pEGFP-N1 at the XhoI and PstI sites. All
point mutations were introduced using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene, Santa Clara, CA, USA), and veriﬁed by
sequencing.
Anti-mouse monoclonal Core antibody (C7-50, Abcam, Cambridge,
United Kingdom), monoclonal NS3 antibody (8G-2, Abcam), anti-
rabbit polyclonal NS5A (provided by Dr. Kunitada Shimotohno,
Kyoto University, Japan), monoclonal anti-Flag (M2, Sigma), anti-HA
(Sigma), anti-Actin (Sigma), anti-cIAPI (provided by Dr. Hongbin
Shu, Wuhan University, China), anti-Calnexin (Ab10286, Abcam),
anti-human E2 antibody (C1) (Gastaminza et al., 2006) (provided byDr. Denis Burton, The Scripps Research Institute, USA), and anti-
mouse NS3 (CC3, Center for Bioengineering and Biotechnology,
Henan, China) were used in the study.
Cell culture and transfection
Cell culture conditions were described previously (Zhong et al.,
2006). Plasmid DNA transfection in Huh7 and Huh7.5.1 cells was
performed with Lipofectamin 2000 (Invitrogen) according to the
manufacturer's instructions.
In vitro transcription, HCV RNA transfection, indirect immunoﬂuorescence,
titration analysis, HCV infection kinetics assay and western blot
These procedures were as described previously (Li et al., 2010;
Zhong et al., 2006).
Confocal laser scanning microscopy
The cells were washed with PBS and ﬁxed in 4% paraformaldehyde
for 30 min at room temperature. Fixed cells were washed three times
with PBS and the nuclei were stained with Hoechst for 30 min at
room temperature. GFPﬂuorescencewas examined directly by confocal
laser scanning microscopy (DM6000B, Leica, Germany).
Peptide synthesis and circular dichroism analysis
Peptides NS3[10–24]-WT (TRGLLGAIVVSMTGR), NS3[10–24]-
M21P (TRGLLGAIVVSPTGR) were synthesized and puriﬁed to the
purity of >98% by RP-HPLC (GLBiochemLtd, Shanghai, China). Circular
dichroismwas performed according to the protocol described previously
(Brass et al., 2008). Brieﬂy, 45 μM of peptides were dissolved in the
membrane mimic buffer 1% lysophosphatidyl choline. Circular dichroism
spectra were recorded from 190 nm to 250 nmwavelength range with a
0.2-nm increment, 0.5-nm bandwidth, and one-second response time on
a J700 spectrometer (J-715, JASCO, Tokyo, Japan). Spectra were baseline
corrected, smoothed and processed using the JASCO program J-700.
Membrane fractionation assay
Membrane fractionation assaywas performedusing a cyto-mem-nucl
fraction kit (Applygen Technologies Inc, Beijing, China). Brieﬂy, ten
million Huh7.5.1 cells were lysed in 0.5 ml of cytosol extraction reagent
buffer and put on ice for 2 min. Lysateswere douce-homogenized for 45
times, sheared by 10 passages through a 21-gage needle, and
centrifugated at 800×g for 5 min at 4 °C. Supernatants containing the
cytosol-membrane fraction were collected and mixed with 35 μl of
membrane extraction reagent buffer on ice for 5 min, and then
centrifugated at a maximum speed of 14000×g for 30 min at 4 °C.
The supernatants containing the cytosolic fraction and the pellets
containing the membrane fraction were collected respectively.
Membrane ﬂoatation assay
Membrane ﬂoatation assay has been described previously (Penin
et al., 2004). Brieﬂy, 2×107 U2-OS cells transfected with plasmids
expressing thewild-type orM21P NS3-NS4Awere Dounce homogenized
in the hypotonic buffer (10 mM Tris–HCl, pH 7.52 mM MgCl2)
supplemented with complete protease inhibitor cocktail (Roche,
Basel, Switzerland) followed by centrifugation at 1,000 g for 5 min
to pellet nuclei and unbroken cells. Supernatant was mixed with
100% sucrose in TNE buffer (100 mM NaCl, 10 mM Tris, 1 mM
EDTA, pH 7.4) to a ﬁnal sucrose concentration of 73%, and placed at
the bottom of a centrifuge tube. Then 65% sucrose in TNE and
10% sucrose were layered on top of the 73% sucrose successively and
centrifuged at 35,000 g for 16 h at 4 °C. Ten fractions were collected
222 Y. He et al. / Virology 422 (2012) 214–223from the top and the distribution of NS3 proteins was analyzed by
western blot.
Expression and puriﬁcation of recombinant NS3 proteins
Escherichia coli Rosetta/pLysS (Novagen) containing pET21b vector
expressing C-terminally 6X His-tagged NS3 protein was induced with
1 mM IPTG at 18 °C for 4 h. Cells were suspended in suspension buffer
(50 mM NaH2PO4 pH 8.0, 500 mM NaCl, 0.1% Triton X-100, 0.1%
2-mercaptoethanol, 1 mM PMSF, and 2 mM imidazole) and lysed by
sonication. After centrifugation at 12000 g for 30 min at 4 °C (Beckman
JA rotor), the supernatantwas incubatedwithNi-NTA agarose (Qiagen),
and bound NS3 proteins were eluted with elution buffer (500 mM
NaCl, 20 mM Tris/HCl, pH 8.0, 0.1% Triton X-100, and 0.1% 2-
mercaptoethanol, 250 mM imidazole). Proteins were loaded onto a
fast performance liquid chromatography (FPLC) Superdex-200 gel
ﬁltration column equilibrated in FPLC buffer (50 mM Tris–HCl, pH
8.0, 1 mM EDTA, 10% glycerol, and 1 mM DTT, 500 mM NaCl). The
purity of isolated proteins was examined by electrophoresis on a
10% SDS-polyacrylamide gel electrophoresis gel and stained with
coomassie blue. Puriﬁed proteins were stored at −80 °C.
NTPase assay
A 10 μl reaction mixture was made with 50 mM Tris pH 7.0, 2 mM
MgCl2, 1 mM cold GTP spiked with 5 uCi [γ-32P] GTP (PerkinElmer,
Waltham, MA, USA), 5 pmol template and 5 pmol NS3 proteins. The
reaction mixture was incubated at 37 °C for 30 min and stopped
with 50 mM EDTA. One-tenth of the reaction mixture was spotted
onto a thin-layer chromatography plate coated with polyethyleneimine
cellulose (Sorbent Technologies, Norcross, GA, USA). Radioactive
phosphate hydrolyzed from [γ-32P] GTP was separated by thin-layer
chromatography using 1.5 M KH2PO4 (pH 3.5) as a running buffer.
Hydrolyzed phosphatewas quantiﬁedwith a PhosphorImager (Typhoon,
GE Healthcare, Piscataway, NJ, USA).
Helicase assay
NS3 helicase activity was measured in a 10 μl reaction mixture
containing 20 mM HEPES, pH 7.5, 2 mM dithiothreitol, 100 μg/ml
bovine serumalbumin, 3 mMMgCl2, enzyme and substrate as indicated,
and 0.5 pmol of a 30-nucleotide capture oligonucleotide (5′-TTAA-
CCGCCGCCCAGGTGTGAGGA-GTACCA-3′). The reaction was initiated by
addition of 5 mM ATP and incubated at 37 °C for 30 min, and stopped
by addition of glycerol loading buffer containing 20 mM EDTA and
0.5% SDS. Products were analyzed in a 12% native polyacrylamide gel
and quantiﬁed with a PhosphorImager (Typhoon, GE).
NS3-NS4A interaction analysis
The recombinant wild-type andM21P NS3 proteins were prepared as
described above. NS4A peptide (STWVLAGGVLAAVAAYCLATGCV-
SIIGRLHVNQRVVVAPDKEVLYEAFDEMEEC{K-(Bio)}KKK)was synthesized
and puriﬁed by RP-HPLC (purity>97%) with biotin labeled at its
C-terminus (GL Biochem Ltd, Shanghai, China). The assay was performed
with a Biacore T100 SPR biosensor instrument with 100 nM NS4A
dissolved in HBS-ET buffer (50 mM HEPES, pH 7.4, 150 mM NaCl,
3 mM EDTA, 0.005% Tween 20) immobilized to the SA chip
through the interaction of biotin-strepavidin at 10 μl/min for 20 s,
with three repeated injections. This procedure generated surfaces
of NS4A and blank. Interaction experiments were carried out at
25 °C with HBS-ET as the running buffer. Different concentrations
of NS3 from 20.8 nM to 416 nM were injected as analyte to ﬂow
through the NS4A coupled surfaces at rate of 30 μl/min and with
contact time of 3 min. Analysis of the sensorgrams was performed
using Biacore T100 Evaluation software (GE Heathcare Life Sciences).Kinetic parameters of the interactions were determined by global
analysis of at least four concentrations of the analyte using an
equation representing the 1:1 binding model. The parameters of Chi2
and U-value were included for the quality control.
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